FDA Inspection 1290416 — Steven D. Abramowitz, M.D.
The FDA completed an inspection of Steven D. Abramowitz, M.D. on October 30, 2025 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 30, 2025
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Washington, DC (United States)
Additional Details
Clinical Investigator (CI)